← Leaderboards
Catherine Burkhart
Buffalo Biolabs, Llc
$1,645,489
Attributed
$1,645,489
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2009–11$2M$1.5M$1M$500K$0
'09
'10
'11
Funding mix
By agency
NIH$1,645,489 · 2
By mechanism
N44$1,496,764 · 1
N43$148,725 · 1
Top collaborators
No co-investigators on record.
Most similar at Buffalo Biolabs, Llc
Same institution · by research overlap
- Vadim Mett$804,501
- Olga B Chernova$330,032
- Katerina Gurova$479,664
- Arindam Sen$486,212
Others in their field
Top investigators on “Antineoplastic Agents”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,409,738
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Gregory H Reaman · National Childhood Cancer Foundation$94,722,934
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Walter John Curran · Thomas Jefferson University$55,187,978
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
Research focus
Antineoplastic AgentsBiological Adaptation To StressBiomarkerCancer TypeContractsDrug Delivery SystemsEvaluationGlioblastomaGrowthHeat-Shock ResponseMalignant Neoplasm Of ProstateMalignant NeoplasmsMaximum Tolerated DoseMutationNon-Small-Cell Lung CarcinomaNormal Tissue MorphologyPathway InteractionsPharmaceutical PreparationsPrimary Carcinoma Of The Liver CellsProtein FunctionRegimenRenal Cell CarcinomaResponseSafety